Astellas Pharma (YPH) Revenue
Astellas Pharma Revenue
Astellas Pharma had a revenue of 640.91B in the quarter ending Jun 30, 2026, with 19.15%. This bring the company's revenue in the last twelve months to 2.27T, Increased 6.32%. In the fiscal year ending Mar 31, 2026, Astellas Pharma had annual revenue of 2.14T with 11.87% growth.
- Revenue (ttm)
- 2.27T
- Revenue Growth
- 5.55%
- P/S Ratio
- 0.01
- Revenue/Employee
- EUR 151,730,265
- Employees
- 14,099
- Market Cap
- EUR 26.22B
Revenue Chart
Astellas Pharma Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 2.14T | 226.92B | 11.87% |
| Mar 31, 2026 | 1.91T | 308.65B | 19.25% |
| Mar 31, 2025 | 1.60T | 85.05B | 5.60% |
| Mar 31, 2024 | 1.52T | 222.46B | 17.16% |
| Mar 31, 2023 | 1.30T | 46.63B | 3.73% |
| Mar 31, 2022 | 1.25T | -51.31B | -3.94% |
| Mar 31, 2021 | 1.30T | -5.50B | -0.42% |
| Mar 31, 2020 | 1.31T | 6.03B | 0.46% |
| Mar 31, 2019 | 1.30T | -11.35B | -0.87% |
| Mar 31, 2017 | 1.31T | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.